Skip to main content

Stonepine Capital Management, LLC

Position in EOLS — Evolus, Inc.

CIK 1440771 BEND, OR

Position in EOLS

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$11,035,724
+$3,805,860 QoQ
Shares Held
1,590,162
-9.6% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
8.39%
of 13F equity value
Holder Rank
#10
of 158 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Derivatives in EOLS

reported options exposure · as of Jun 30, 2026
CallValue
$2,914,800
CallShares
420,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $17,591,704 across 4 Drug Manufacturers - Specialty & Generic names. EOLS ranks #1 (62.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EOLS
Evolus, Inc.
This page
1,590,162 $11,035,724

All Filings in EOLS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,914,800 420,000
2026-06-30 $11,035,724 1,590,162
2026-03-31 $7,229,864 1,759,091
2026-03-31 $1,726,200 420,000
2025-12-31 $10,850,060 1,631,588
2025-09-30 $9,433,440 1,536,391
2025-06-30 $8,440,965 916,500
2025-03-31 $13,648,925 1,134,574
2024-12-31 $13,961,747 1,264,651
2024-09-30 $22,191,100 1,369,821
2024-06-30 $17,985,079 1,657,611
2024-03-31 $37,440,984 2,674,356
2023-12-31 $56,156,532 5,333,004
2023-09-30 $47,336,096 5,179,004
2023-06-30 $32,760,052 4,506,197
2023-03-31 $4,896,605 578,795
2022-12-31 $6,266,584 834,432
2022-09-30 $1,610,000 200,000
2022-03-31 $6,577,433 586,224
2021-12-31 $12,128,754 1,863,096
2021-09-30 $2,286,000 300,000
2020-03-31 $3,415,284 822,960